Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Danish Headache Center |
---|---|
Information provided by: | Danish Headache Center |
ClinicalTrials.gov Identifier: | NCT00291395 |
Before , during and after intravenous administration of PGI2 we score/measure headache, rCBF, blood flow in middle cerebral artery and diameter of superficial temporal artery/radial artery and correlate that to known patophysiology of headache to see if PGI2 is involved in headache pathophysiology.
Condition | Intervention | Phase |
---|---|---|
Headache Migraine |
Drug: PGI2 |
Phase I |
Study Type: | Interventional |
Study Design: | Randomized, Double-Blind, Placebo Control, Crossover Assignment |
Ages Eligible for Study: | 18 Years to 40 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | KA05055 |
Study First Received: | February 13, 2006 |
Last Updated: | October 25, 2006 |
ClinicalTrials.gov Identifier: | NCT00291395 |
Health Authority: | Denmark: Ethics Committee |
Signs and Symptoms Migraine Disorders Headache Epoprostenol Central Nervous System Diseases Neurologic Manifestations |
Headache Disorders, Primary Pain Healthy Brain Diseases Headache Disorders |
Nervous System Diseases |